FdaApplication

ANDA 211337

Back to search

Identifiers

Properties

PropertyValue
applicant_nameREYOUNG CORPORATION
application_typeANDA
approval_date2023-03-02

Products (1)

ProductActive ingredientStrengthDosage form
TENOFOVIR DISOPROXIL FUMARATETENOFOVIR DISOPROXIL FUMARATE300MGTABLET;ORAL

1 product